Germany dominated the market with a 24.85% share in 2024, driven by strong biopharmaceutical R&D investments, high adoption ...

The Platform Technology Designation, which precedes the current FDA leadership, is designed to streamline the drug ...

The health outcomes speak for themselves: France ranks third globally in child well-being, while the U.S. ranks 36 th. The ...

Fraunhofer IAF's semi-automated process for MOEMS-EC-QCLs enhances manufacturing efficiency, reducing costs and enabling real ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...